Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2007-05-01

Original market date: See footnote 1

1972-12-31

Product name:

KETALAR

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

00224391

Product Monograph/Veterinary Labelling:

Date: 2020-10-07 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

ERFA CANADA 2012 INC
8250 Blvd Decarie, Suite 110
Montreal
Quebec
Canada  H4P 2P5

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous,  Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Narcotic (CDSA I)  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

28:04.92   MISCELLANEOUS GENERAL ANESTHETICS

Anatomical Therapeutic Chemical (ATC): See footnote 4

N01AX03  KETAMINE

Active ingredient group (AIG) number:See footnote 5

0131360002

List of active ingredient(s)
Active ingredient(s) Strength
KETAMINE (KETAMINE HYDROCHLORIDE) 10 MG / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: